Aerovance, Inc. Report issue

For profit Phase 2
Founded: Berkeley CA United States (2004)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2005
NCT00535028
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

ipratropium (atrovent) (3 trials)

pitrakinra (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 2